Skip to main content

Want a detailed portfolio tracker?

CAMP4 Therapeutics (CAMP) P/E (2024 - 2026)

CAMP4 Therapeutics (CAMP) P/E from Dec 31, 2024 to Jul 21, 2026. The TTM CAMP4 Therapeutics (CAMP) P/E is -1.54. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CAMP4 Therapeutics (CAMP)

YearP/EChange
2026-1.54-41.35%
2025-2.62-66.91%
2024-7.92N/A

Comparison CAMP4 Therapeutics (CAMP) P/E with competitors

CAMP4 Therapeutics (CAMP) P/E is -1.54.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.11%
NBYStablecoin Development Corp0.00-100.28%
ENLVEnlivex Ltd0.07-104.87%
FGENFibroGen Inc0.24-115.62%
CHRSCoherus Biosciences Inc0.85-155.21%
FBIOFortress Biotech Inc0.95-161.75%
ORMPOramed Pharmaceuticals Inc1.50-197.80%
AGENAgenus Inc3.01-295.82%
INVAInnoviva Inc3.15-305.22%
VXRTVaxart Inc3.55-330.96%
CRMDCorMedix Inc3.63-336.08%
CVACCureVac N.V.4.45-389.26%
GLPGGalapagos NV4.86-416.14%
SRPTSarepta Therapeutics Inc4.88-417.65%
ABEOAbeona Therapeutics Inc5.39-450.54%
ABUSArbutus Biopharma Corp5.60-464.08%
ZVRAZevra Therapeutics Inc5.89-483.05%
SPROSpero Therapeutics Inc6.23-505.25%
CGENCompugen Ltd6.31-510.81%
RIGLRigel Pharmaceuticals6.87-547.13%
SLXNSilexion Therapeutics Corp7.30-574.72%
OMEROmeros Corporation9.26-702.42%
AUPHAurinia Pharmaceuticals Inc9.58-723.64%
PLXProtalix BioTherapeutics Inc10.89-808.62%
ACADAcadia Pharmaceuticals Inc11.73-863.11%
TBPHTheravance Biopharma Inc12.26-897.83%
ADMAAdma Biologics Inc12.42-907.98%
HRMYHarmony Biosciences Holdings Inc13.82-999.21%
SABSSAB Biotherapeutics Inc14.14-1019.77%
NAGENiagen Bioscience Inc14.82-1064.14%
INCYIncyte Corp15.82-1129.49%
REGNRegeneron Pharmaceuticals Inc15.86-1131.71%
PBYIPuma Biotechnology Inc17.32-1226.64%
CPRXCatalyst Pharmaceuticals Inc17.44-1234.69%
EXELExelixis Inc17.54-1241.11%
TGTXTG Therapeutics Inc18.97-1334.02%
MDXGMimedx Group Inc20.55-1437.25%
XOMAXOMA Royalty Corp22.87-1588.38%
ARGXArgen X SE24.30-1680.99%
CTMXCytomX Therapeutics Inc24.82-1715.02%
XOMAOXOMA Royalty Corp25.34-1749.10%
HALOHalozyme Therapeutics Inc25.62-1767.25%
XOMAPXOMA Royalty Corp25.67-1770.27%
VRTXVertex Pharmaceuticals Inc27.99-1921.52%
RPRXRoyalty Pharma plc - Class A28.69-1966.60%
SLNOSoleno Therapeutics Inc29.02-1987.93%
ASNDAscendis Pharma A/S30.09-2057.56%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2566.80%
APLSApellis Pharmaceuticals Inc39.02-2638.98%
BMRNBiomarin Pharmaceutical Inc42.21-2846.58%
KRYSKrystal Biotech Inc45.34-3050.34%
ONCBeiGene Ltd69.54-4624.76%
PHARPharming Group N.V.75.03-4981.66%
TECHBio-Techne Corp101.96-6734.09%
VCELVericel Corp109.92-7252.21%
ALNYAlnylam Pharmaceuticals Inc117.96-7775.59%
GMABGenmab140.29-9228.25%
TLXTelix Pharmaceuticals Ltd162.15-10650.74%
CORTCorcept Therapeutics Inc212.86-13949.92%